BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12353705)

  • 1. In vitro activity of phytosphingosines against Malassezia furfur and Candida albicans.
    Nenoff P; Haustein UF
    Acta Derm Venereol; 2002; 82(3):170-3. PubMed ID: 12353705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition of Malassezia species by pharmacological concentrations of polidocanol.
    Mayser P; Gründer K
    Mycoses; 1995; 38(1-2):23-7. PubMed ID: 7637678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of Malassezia furfur against rilopirox.
    Nenoff P; Haustein UF
    Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antifungal activity of a coal tar gel on Malassezia furfur in vitro.
    Nenoff P; Haustein UF; Fiedler A
    Dermatology; 1995; 191(4):311-4. PubMed ID: 8573928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Pityrosporum ovale (Malassezia furfur) to human androgenic steroids.
    Brasch J
    Mycopathologia; 1993 Aug; 123(2):99-104. PubMed ID: 8264774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polidocanol sensitivity--a possible tool in the differentiation of Malassezia spp.
    Mayser P; Haze P; Pickel M
    Mycoses; 1997 Dec; 40(9-10):391-5. PubMed ID: 9470429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
    Sancak B; Ayhan M; Karaduman A; Arikan S
    Mikrobiyol Bul; 2005 Jul; 39(3):301-8. PubMed ID: 16358489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia.
    Hammer KA; Carson CF; Riley TV
    J Med Vet Mycol; 1997; 35(5):375-7. PubMed ID: 9402533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions.
    Youngchim S; Nosanchuk JD; Chongkae S; Vanittanokom N
    Arch Dermatol Res; 2017 Jan; 309(1):47-53. PubMed ID: 27885419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriacitrin--a potent UV filter produced by Malassezia furfur and its effect on human skin microflora.
    Machowinski A; Krämer HJ; Hort W; Mayser P
    Mycoses; 2006 Sep; 49(5):388-92. PubMed ID: 16922790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro anti-Malassezia activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb.
    Rukayadi Y; Hwang JK
    Lett Appl Microbiol; 2007 Feb; 44(2):126-30. PubMed ID: 17257249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of modified Leeming-Notman media in a resazurin microtiter assay in the evaluation of in-vitro activity of fluconazole against Malassezia furfur ATCC 14521.
    Far FE; Al-Obaidi MMJ; Desa MNM
    J Mycol Med; 2018 Sep; 28(3):486-491. PubMed ID: 29753721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiamine antivitamins--an opportunity of therapy of fungal infections caused by Malassezia pachydermatis and Candida albicans.
    Siemieniuk M; Czyzewska U; Strumilo S; Tylicki A
    Mycoses; 2016 Feb; 59(2):108-16. PubMed ID: 26691773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs.
    Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF
    Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphatidate phosphatase activity from the yeast Saccharomyces cerevisiae by sphingoid bases.
    Wu WI; Lin YP; Wang E; Merrill AH; Carman GM
    J Biol Chem; 1993 Jul; 268(19):13830-7. PubMed ID: 8314751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of lithium succinate against Malassezia furfur.
    Nenoff P; Haustein UF; Münzberger C
    Dermatology; 1995; 190(1):48-50. PubMed ID: 7894097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro.
    Payne CD; Ray TL; Downing DT
    J Invest Dermatol; 1996 Mar; 106(3):549-52. PubMed ID: 8648192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Activity of Thapsia villosa Essential Oil against Candida, Cryptococcus, Malassezia, Aspergillus and Dermatophyte Species.
    Pinto E; Gonçalves MJ; Cavaleiro C; Salgueiro L
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28937623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.
    Iatta R; Immediato D; Montagna MT; Otranto D; Cafarchia C
    Med Mycol; 2015 Apr; 53(3):269-74. PubMed ID: 25631480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
    Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
    Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.